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A class of anti-virulence compounds, the salicylidene acylhy-
drazides, has been widely reported to block the function of the
type three secretion system of several Gram-negative pathogens
by a previously unknown mechanism. In this work we provide
the first identification of bacterial proteins that are targeted by
this group of compounds. We provide evidence that their mode
of action is likely to result from a synergistic effect arising from
a perturbation of the function of several conserved proteins.We
also examine the contribution of selected target proteins to the
pathogenicity of Yersinia pseudotuberculosis and to expression
of virulence genes in Escherichia coliO157.
As the prevalence of antibiotic-resistant strains increases, tar-
geting virulence determinants of pathogenic bacteria has become
an attractive alternative to the use of traditional bactericidal anti-
biotics (1–5). A key feature of this strategy is that the virulence-
blocking compounds spare the endogenous microflora and
thereby exert less selective pressure, which in turn should reduce
development of resistance. One potential target is the bacterial
type three secretion system (T3SS),7 a conserved protein injection
organelle that is central to the virulence of many human, animal,
and plant pathogens including Chlamydia sp., enteropathogenic
and enterohemorrhagic Escherichia coli, Pseudomonas aerugi-
nosa, Salmonella sp., Shigella sp., and Yersinia sp. (6, 7). With
the T3SS, the pathogen translocates effector proteins into the
cytosol of the host cell and thereby creates a niche that allows
bacterial growth. A class of virulence-blocking compounds, the
salicylidene acylhydrazides, was originally identified as putative
T3SS inhibitors in Yersinia pseudotuberculosis (8). In a number
of publications the compounds have been shown to be broadly
effective in negatively affecting the function of the T3SS in a
number of pathogenic bacteria including Chlamydia sp.
(9–12), Salmonella typhimurium (13, 14), Y. pseudotuberculo-
sis (15), Shigella sp. (16), and E. coli O157 (17). Two reports
describe activity of the compounds in vivo (13, 18) and thus
indicate that T3SS inhibitors have the potential to be developed
into novel anti-bacterial agents (19, 20). In addition, small mol-
ecule inhibitors can be used as chemical probes to study the role
of T3SS in bacterial pathogenesis (12, 21, 22). To date, the
mechanism of inhibition for the salicylidene acylhydrazides has
been unclear with several mechanisms being postulated,
including direct effects on theT3SSmachinery or on regulatory
proteins that affect T3SS expression (15–17). The activity of
salicylidene acylhydrazides on Chlamydia trachomatis can be
reversed by the addition of iron, suggesting a possible link to
iron availability in the cell (11).
Although target-based screening can identify compounds
that perturb the function of the selected protein, the activity is
often lost when the compounds are tested on bacterial cells due
to a lack of bacterial cell permeability (23). Phenotypic screens
circumvent this challenge and directly provide compounds that
are active on the cellular level. The salicylidene acylhydrazides
were identified using this strategy, and this is likely the under-
lying reason for the broad activity spectrum observed for these
T3SS inhibitors. The drawback is, however, that the mode of
action at the molecular level has to be studied at a later stage.
Identification of the cellular targets for the salicylidene acylhy-
drazides constitutes a crucial step in understanding their true
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mode of action.Moreover, such data are essential for the struc-
ture-led design and improvement of any potential therapeutic
compound. Affinity chromatography, expression-cloning tech-
nologies, and microarrays are among the many strategies that
can be employed for target deconvolution (24). To help under-
stand the molecular mechanism by which salicylidene acylhy-
drazides affect the T3SS, we aimed to identify the target pro-
teins bound by this class of novel antibacterial compounds
using an affinity reagent strategy (25). In this study we describe
synthesis of aT3SS inhibitor affinity reagent and the isolation of
putative target proteins from E. coliO157. By a series of in vitro
experiments, we show that the compounds directly and selec-
tively interact with the target proteins WrbA, Tpx, and FolX.
The genes encoding the target proteins were deleted individu-
ally in both E. coli O157 and Y. pseudotuberculosis, and we
show that the proteins are involved in regulation of T3SS gene
expression. Our work provides the first identification of the
cellular targets for this group of compounds and convincing
evidence that their mode of action is likely to result from a
synergistic effect arising from a perturbation of the function of
several conserved proteins.
EXPERIMENTAL PROCEDURES
Strains, Plasmids, and Construction of Mutants—Bacterial
strains and plasmids used in this study are listed in supplemen-
tal Table S1. Mutations in tpx were made using QuikChange II
(Stratagene) and were confirmed by sequencing. Oligonucleo-
tides (Invitrogen) are listed in supplemental Table S2. E. coli
O157 strains were cultured in LB, DMEM, or MEM-HEPES
media (Sigma) supplemented with standard concentrations of
antibiotics (26).
Affinity Chromatography Using Affi-Gel-labeled Salicylidene
Acylhydrazides—The stepwise synthesis of ME0055-Aff is
described in supplemental Protocol S1. E. coli O157 strain
TUV93–0 was cultured in MEM-HEPES media at 37 °C to an
A600 0.8. Cells were harvested and lysed using a French pres-
sure cell. No subsequent separation steps were used to ensure
that cell wall, cell membrane, and cytosolic proteins were rep-
resented in the lysate. The bacterial lysate wasmixed with PBS-
balanced ME0055-Aff beads overnight at 4 °C. The beads were
separated by centrifugation at 500 g for 5 min. An aliquot of
the supernatantwas saved for analysis, and the rest of the super-
natant was discarded. The beadswerewashed 10 times using 10
volumes of PBS and separation by centrifugation at 500 g for
5 min. The beads were mixed gently in the same volume of 20
M ME0055 and incubated at room temperature for 30 min.
Supernatant was collected by centrifugation at 500  g for 5
min. The elution and centrifugation step was repeated with 200
M ME0055 and 1% acetic acid, respectively. Equal volumes of
washes and eluates were loaded onto the protein gels. Samples
were visualized using Colloidal Blue Stain (Invitrogen), and
bands were excised for subsequent in-gel digestion and analysis
(27). Proteins analyzed by peptide mass fingerprinting were
given a MOWSE score (28) to indicate the probability of the
identification being correct. We set a threshold MOWSE value
of 100 or greater, ensuring a significance of p 108.
Screening for Protein Secretion and Western Blot Analyses—
Eighteen bacterial strains (supplemental Table S1) were cul-
tured overnight in LB and diluted to an A600  0.05 in pre-
warmed MEM-HEPES medium. Cultures were grown at 37 °C
to an A600 0.8, and then secreted proteins were extracted by
TCA precipitation as described previously (29). Proteins were
analyzed by SDS-PAGE, andWestern blotting for Tir and EspD
was carried out as described previously (29). Strain 430 dis-
played no reduction in secretion upon the addition of 20 M
ME0052, ME0053, ME0054, or ME0055 to the culture when
assessed by Western blotting for Tir or EspD.
Re-sequencing of ZAP 430—Genomic DNA for the ZAP 430
strain was extracted using a QIAamp DNA extraction kit. The
sequencing was performed in the Sir Henry Wellcome Func-
tional Genomics Facility, University of Glasgow, using the Illu-
mina Genome Analyzer II platform. The purified genomic
DNA was randomly fragmented with a Bioruptor Sonicator
(Diagenode Inc., NJ) followed by the ligation of adapters, and
genomic library generation was performed according to the
standard Illumina protocol. The genomic library at a concen-
tration of 3 pMwas then loaded onto a single lane of the Illumina
flow cell, and the DNA clusters were generated using the Illu-
mina Single Read Cluster Generation kit Version 4 (Illumina
Inc.). Subsequently, 70 cycles of single end sequencing were
performed. The raw data containing read sequences and asso-
ciated qualities were generatedwithGenomeAnalyzer Pipeline
v.1.5 (Illumina Inc.). Of 15,712,834 70-bp-long reads generated,
14,347,057 were successfully mapped to the E. coli O157:H7
strain EC4115 complete genome (GenBankTM accession
NC_011353) using Maq software with the default parameter
set, which resulted in 179 genome coverage. Subsequently,
the SNPs were identified with Maq and filtered with the com-
mand “maq.pl SNPfilter -q 40 -w 5 -N2 -d 3 -D256 -n 20 -Q40,”
where parameters were chosen as suggested for the bacterial
genomes (30). The latter identified 1348 SNPs (supplemental
Table S3).
Far Western Blotting—The stepwise synthesis of ME0052-
Bio and ME0055-Bio are described in supplemental Protocol
S1. Target proteins were overexpressed in E. coli BL21 (DE3).
Bacterial pellets were lysed using 8 M urea, and the supernatant
was collected by centrifugation at 14,000 g for 1min. The Far
Western analysis was performed as described previously (31)
usingNovexNuPAGE 4–12%BisTris SDS-PAGE gels (Invitro-
gen), 20 M ME0052-Bio as the probe, and HRP-conjugated
streptavidin (Invitrogen) for the detection of biotin. Protein
loading was checked by using an anti-His antibody that showed
equivalent levels of overexpressed target protein in each lane
(data not shown).
Analyses of Transcript Levels—Transcriptional profiling of
E. coliO157 strains was carried out essentially as described pre-
viously (32). Overnight cultures of E. coli TUV-930 or defined
mutants were grown in MEM-HEPES (Sigma) supplemented
with 250 nM Fe(NO3)2 and glucose to a final concentration of
0.2% and then diluted to anA600 0.1 in the samemedia. At an
A600 0.8, 15-ml cultures were stabilized in an equal volume of
RNAprotect (Qiagen), and RNA was extracted using a Qiagen
RNeasyMini kit. DNA contamination was removed by DNase I
treatment (Ambion). Total RNA was assessed for quality and
quantified using an Agilent 2100 Bioanalyzer. Synthesis of
cDNAand labeling of total RNAwas performedusing anAmer-
Target Proteins of the Salicylidene Acylhydrazides
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sham Biosciences CyScribe post-labeling kit as per the manu-
facturer’s instructions. The cDNA was hybridized to 70-mer-
spotted oligonucleotide arrays containing ORFs from E. coli
K-12, E. coli Sakai VT2, and E. coli EDL933 (University of Bir-
mingham) using a Genomic Solutions GeneTac hybridization
machine. Hybridized slides were scanned using a Genepix
4000A scanner and GenePix 7.0 software (Axon Instruments,
Union City, CA). Data were analyzed using Genespring GX
7.3.1 (Agilent).
Quantitative PCR—Triplicate wild-type andmutant cultures
were grown up inMEM-HEPES. RNA extractions were carried
out using a Qiagen RNeasy Mini kit, and cDNA synthesis was
carried out using a Qiagen QuantiTectTM Reverse Transcrip-
tion kit. Duplicate quantitative PCRs were carried out using a
Qiagen QuantifastTM SYBR Green PCR kit and Stratagene
MX3000, and oligonucleotide primers are listed in supplemen-
tal Table S2. All the experiments were performed according to
the manufacturer’s instructions.
Visualization of Flagella and EspA Filaments—Flagella and
EspA filaments were visualized using immunofluorescence
microscopy (17). Images were processed and quantified using
Volocity suite software (PerkinElmer Life Sciences). Bacterial
motility was assayed using soft agar plates as described previ-
ously (33).
Purification and Biophysical Studies of Tpx from Y. pseudo-
tuberculosis (ypTpx)—ypTpx and ypTpxC61S were cloned,
expressed, and purified as described previously (34). For NMR
spectroscopy, ypTpxwas expressed inM9minimalmedia, with
the nitrogen source substituted with 15NH4Cl. Experiments to
identify chemically-shifted residues were performed using tri-
ple-labeled Tpx (13C,2H,15N), produced by culture in algal
hydrolysate-based media (Cambridge Isotopes Ltd). For chem-
ical shift perturbation studies, ypTpx NMR samples were pre-
pared to contain 100 M protein in 13 mM KPi, pH 7.4, 33 mM
NaCl, and 5% D2O, and 15N FAST-HSQC (35) spectra were
recorded at 298 K and 14.1 T using a Bruker AVANCE 600
spectrometer equipped with a 5-mm TCI cryoprobe. Com-
poundwas added from a concentrated stock solution in deuter-
ated DMSO (dDMSO), and reference spectra recorded with an
equal concentration (0.33% v/v) of dDMSO added. Backbone
resonance assignment was achieved using triple resonance, and
TROSY (transverse relaxation optimized spectroscopy) triple
resonance experimentswere recorded from150 to 500M sam-
ples at 308 K. Data were processed using AZARA and analyzed
using CCPNMR analysis (36).
Analytical Ultracentrifugation (AUC) of Tpx and ME0052—
Before AUC analysis, ypTpx and ypTpx C61S were dialyzed
against 20 mM Tris, pH 7.4, 50 mM NaCl. Sedimentation veloc-
ity experiments were performed using an Optima XL-I analyt-
ical ultracentrifuge (Beckman Coulter, Palo Alto, CA) and an
An-50 Ti rotor. Data were collected at 49,000 rpm at 4 °C for
ypTpx under oxidizing (with 10 mM H2O2) and reducing (with
5 mM DTT) conditions and for the C61S mutant. 360 l of
sample (100 M protein solution with ME0052 at concentra-
tions ranging from 0 to 250 M) and reference solvent (20 mM
Tris, pH 7.4, 50 mM NaCl, 1% v/v DMSO) were loaded into
3-mm path length charcoal-filled epon double-sector center-
pieces. Rayleigh interference and absorbance (at 280 and 395
nm) data were collected every 15 min for 25 h (1 replicate of
absorbance data in continuous mode with a radial step size of
0.005 cm). A wavelength of 395 nm was used to monitor the
sedimentation ofME0052 only, as the protein does not contrib-
ute to the signal at this wavelength.
A two-stage analysis of sedimentation velocity data was used
to determine the amount of ME0052 bound to oxidized and
reduced ypTpx and the C61S mutant. First, the number of spe-
cies in the system was evaluated using continuous distribution
(c(s)) analysis, performed with SEDFIT software (37). The sed-
imentation coefficients (s20,w0 ) of oxidized and reduced ypTpx
and the C61S mutant are 3.04, 2.62, and 2.80 s, respectively
(data not shown); thus, a peak with this sedimentation coeffi-
cient in the c(s) distribution derived from sedimentation veloc-
ity data acquired at 395 nm could be attributed to ypTpx bound
to ME0052. At ME0052  0 M no peaks were resolved from
the data; at higher concentrations two peaks were evident: one
at very low s (corresponding to unboundME0052) and the sec-
ond close to 2.7 s (ME0052 bound to protein). The concentra-
tion of free and bound compoundwas determined by fitting the
data with a (two species) non-interacting discrete species
model in SEDFIT. An extinction coefficient of 11,100 M1 cm2,
determined from the linear dependence of absorbance at 395
nmwithME0052 concentration, was used to calculate the con-
centration of compound returned by the non-interacting dis-
crete species model. The resultant reduced data were then fit-
ted with a single-site-binding nonlinear regressionmodel using
the formula Y Bmax X/(Kd X), where Y is the concentra-
tion ofME0052 bound to protein (determined by non-interact-
ing discrete species),X is the total concentration ofME0052 (i.e.
bound and unbound), Bmax is the concentration of compound
required to saturate the protein (i.e. at maximal binding), and
Kd is the equilibrium dissociation constant or concentration of
compound required to reach half-maximal binding. The stoi-
chiometry of interaction between ME0052 and ypTpx was
determined by dividingBmax by the total protein concentration.
RESULTS
Affinity Chromatography Identifies 16 Putative Salicylidene
Acylhydrazide Target Proteins—The two salicylidene acylhy-
drazides ME0052 and ME0055 were selected for chemical
derivatization. ME0052 has been extensively studied and
proved to display low toxicity against mammalian cells and
activity against T3S in Y. pseudotuberculosis, C. trachomatis,
Salmonella enterica, Shigella flexneri, and E. coli O157:H7 (10,
11, 14–17), and ME0055 was selected based on its low toxicity
and high activity against T3S in E. coliO157 (17). The Affi-Gel-
and biotin-labeled salicylidene acylhydrazide derivatives
ME0055-Aff and ME0052-Bio (Fig. 1A) were synthesized by
combined solid phase and solution phase chemistry. The posi-
tion for attachment of the linker was based on previous struc-
ture-activity data (15, 38, 39). ME0055-Aff was used in affinity
chromatography experiments to enrich for inhibitor binding
proteins from E. coli O157 lysates prepared using a French
pressure cell. After incubation, washing, and elution using step-
wise increasing concentrations of unlabeled compound, pro-
teins were resolved by SDS-PAGE and visualizedwith Colloidal
Blue Stain (Fig. 1B). Bands were selected corresponding to the
Target Proteins of the Salicylidene Acylhydrazides
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lanes derived from the fractions that had been eluted using
unlabeled compound but that were less abundant in the lane
associated with the acetic acid “stripping” of the beads. These
were postulated to be true target proteins and not simply bound
to the Affi-Gel bead itself. Bands from the gel were excised to
permit in-gel trypsin digestion and analysis by liquid chroma-
tography electrospray ionization tandem mass spectrometry
(27). Using this approach, we identified 16 proteins (supple-
mental Table S4) that were bound by ME0055-Aff.
Identification and Resequencing of an E. coli O157 Strain
Insensitive to Salicylidene Acylhydrazides—As an independent
screen, a panel of 18 clinical E. coli O157 isolates selected to
represent a diverse range of phage types were tested for sensi-
tivity against four salicylidene acylhydrazides (ME0052,
ME0053, ME0054, and ME0055) that previously proved effec-
tive againstE. coliO157 (17).Western blot analysis of Tir secre-
tion in the presence of 20 M concentrations of each of the
compounds revealed a strain, ZAP 430, that showed no inhibi-
tion of Tir secretion upon the addition of any of the four com-
pounds. Illumina re-sequencing of the genome (EMBL,
ERP000335) and comparison against EC4115, a strain sensitive
to the salicylidene acylhydrazides, demonstrated that ZAP 430
carried numerous mutations (supplemental Table S3). These
mutations include the gene encoding WrbA, one of the target
proteins identified from the affinity chromatography approach.
Previous work has suggested that the salicylidene acylhydra-
zides may function by directly binding and perturbing the pro-
teins associated with the T3SS basal apparatus (16). ZAP 430
had nomutations in the genes encoding the structural proteins
of the T3SS; this insensitive strain contained T3SS proteins
identical to both EDL933 and EC4115, reflecting the high level
of conservation of these proteins.
ME0052-Bio Binds to Tpx,WrbA, and FolX fromE. coli O157—
To facilitate studies of the putative binding proteins, we
attempted to clone the corresponding genes. From the 16
amplified products, 12 genes were successfully cloned into a
pET151 vector and verified by sequencing. Each of the 12 plas-
mids was tested for protein overexpression, with seven clones
producing a protein of the expected size. These seven proteins
were (or were encoded by): Tpx, FolX, z2714, z3974, WrbA,
SurA, and StcE. Interactions with salicylidene acylhydrazides
were tested in Far Western experiments using 20 M concen-
trations of the biotin-labeled compound ME0052-Bio as a
probe (Fig. 2A). From the seven overexpressed proteins, three
gave clear signals after Far Western analysis: Tpx, a thiol per-
oxidase (40), WrbA a NAD(P)H quinine oxidoreductase (41),
and FolX, a dihydroneopterin-tri-P-epimerase (42). No signal
or a very weak signal was seen corresponding to the other four
proteins or for E. coli lysates with no overexpressed target pro-
tein (Fig. 2A). We, therefore, decided to focus on Tpx, WrbA,
and FolX for further studies.
ME0052-Bio and ME0055-Bio Bind to WrbA, Tpx, and FolX
from Multiple Pathogens—Previous work has demonstrated
that salicylidene acylhydrazide compounds inhibit expression
and function of the T3SS in numerous pathogens (19). We
aimed to test if WrbA, Tpx, and FolX were conserved targets
resulting in a common mechanism of inhibition. Cloning and
overexpression of the genes encodingWrbA and Tpx were car-
ried out from five different pathogens: E. coliO157, S. typhimu-
rium, S. flexneri, P. aeruginosa, and Y. pseudotuberculosis. The
gene encoding FolX, which is less conserved, was cloned from
three pathogens: E. coli O157, P. aeruginosa, and S. flexneri.
FolX is not present in Y. pseudotuberculosis, but this species
does carry a structurally and functionally similar protein, FolB,
as do P. aeruginosa and S. typhimurium. To examine the spec-
ificity of the inhibitor-target interaction further, we also cloned
and overexpressed FolB from these three species. Using
ME0052-Bio as a probe for Far Western experiments, we
observed binding with overexpressed WrbA, Tpx, and FolX
from all the species tested (Fig. 2, B–D). Protein loading was
shown to be equivalent for each lane by probing the samples
with an anti-His antibody (data not shown). After separation by
SDS-PAGE, Tpx was detected as a monomer of 19 kDa as well
as a dimer of 38 kDa, which was verified by Tandem MS iden-
FIGURE1.A, shownare structures of compoundsused andvisualizationof the
proteins from the pulldown assay. Structures of the inhibitory compounds,
ME0052 and ME0055, and derivatives, ME0055-Aff and ME0052-Bio, used for
the identification of target proteins are shown. Supplemental Protocol S1
details the syntheses. ME0055-Aff was used in affinity chromatography
experiments to enrich for putative target proteins; ME0055-Bio was used for
Far Western experiments. B, visualization of the protein fractions from the
affinity chromatography procedure is shown. Lysates from E. coli O157 were
incubatedwithME0055-Aff andwashed, and thenproteinswere elutedusing
20 and 200 M unlabeled ME0055. The beads were stripped using 1% acetic
acid. Equal volumes of samples from each fraction were separated by SDS-
PAGE and then visualized using Colloidal Blue Stain. Proteins were excised,
subjected to in-gel trypsin digestion, and analyzed by LC-electrospray ioniza-
tion tandem MS. Each protein identified from the gel is numbered sequen-
tially and is listed in supplemental Table S4.
Target Proteins of the Salicylidene Acylhydrazides
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tification of the excised bands. The presence of both monomer
and dimer after SDS-PAGE indicated that Tpx had a stable
structure and that heat and detergent were unable to com-
pletely denature the protein. The addition of ME0052-Bio
resulted in a signal for both dimer and monomer of Tpx (Fig.
2C). Experiments were repeated using ME0055-Bio and gave
the same results, albeit with a higher level of background signal.
No interaction between ME0052-Bio and FolB was detected
(Fig. 2D), indicating that the compound does not bind this pro-
tein when an equivalent amount of protein is used as bait. This
is despite the fact that FolB and FolX from E. coli display 68%
sequence similarity (as determined using ClustalW), and the
structures superimpose with a root-mean-square-deviation of
1.7Å (PDB codes 2O90 and 1B9L, respectively). The addition of
200 M unlabeled ME0052 (Fig. 2, F–H), in competition with
ME0052-Bio, resulted in a marked reduction in ME0052-Bio
binding to WrbA, Tpx, and FolX irrespective of species.
To investigate the specificity of the interaction between tar-
get protein and inhibitor, we focused further on Tpx, a thiol
peroxidase previously shown to be part of the oxidative stress
defense system that uses reducing equivalents from thiore-
doxin (Trx1) and thioredoxin reductase (TrxR) to reduce alkyl
hydroperoxides (40). Tpx is attractive to study as it is easy to
purify, and conditions for protein crystallization have been
determined (34, 43). The catalytically important residues of
Tpx have been previously identified. Tpx is inactivated by
mutation of cysteine 61 that is essential for intramolecular
disulfide bond formation (40). The mutant protein species is
present only in the structurally reduced form, as it cannot
undergo the disulfide bond formation critical for the catalytic
cycle of the protein. C61S Tpx formed a less stable dimer, and
after SDS-PAGE, themajority of the protein was seen as amon-
omer (data not shown) rather than as a dimer forwild-typeTpx.
The C61S mutation reduced ME0052-Bio binding (Fig. 2E).
NMR Chemical Shift Perturbation Shows That ME0052
Binds to Tpx from ypTpx—We validated the interaction be-
tween ME0052 and Tpx by NMR chemical shift perturbation.
15Nheteronuclear SingleQuantumCoherence (HSQC) spectra
of 100 M ypTpx recorded in the absence and presence of
excess ME0052 revealed chemical shift changes specific to a
small number of cross-peaks originating from particular back-
bone amides (Fig. 3). The shift changes increased graduallywith
increasing ligand concentration, indicating that the free and
ligand-bound protein were in fast exchange and were saturated
by 200 M ME0052. No shifts were seen with the addition of
DMSO alone. 81% of the backbone amide resonances were
assigned, and the chemical shift changes mapped to the struc-
ture. These data indicate that the compound binds to a specific
site on ypTpx, inducing only minor conformational changes.
Identification of Residues Involved in the Binding of ME0052
and Modeling of the Site—Based on the residues shown to be
perturbed by NMR, ME0052 was docked into the published
structure of E. coli O157 Tpx (ecTpx) (PDB code 3HVV (43))
using the program Autodock Vina in PyMOL (44, 45). There is
a high sequence identity between Tpx from E. coli and Y. pseu-
dotuberculosis, comprising 80% overall identity with 100% sim-
ilarity in the residues affected by binding. As PDB code 3HVV is
the structure of a C61S mutant, residue 61 was replaced with a
cysteine to mimic the reduced structure. Residues that were
shown to have the greatest NMR chemical shifts are colored
purple for reference (Fig. 4). The binding site of ME0052 with
Tpx forms near the dimer interface and comprises both sub-
units albeit with an unequal contribution, as can be seen on Fig.
4A. The residue with the largest shift is Val-60, adjacent to the
catalytically active residue of Tpx.
Determination of Binding Affinity and Stoichiometry—The
salicylidene acylhydrazide compounds have a defined absorb-
ance peak at 395 nm.This enabled binding of the compounds to
ypTpx in solution to be examined using AUC. The concentra-
tion of ME0052 bound to ypTpx was determined for a range of
total compound concentrations. These data were used to cal-
culate the dissociation constant (Kd) and the stoichiometry of
binding. Using this approach, the Kd for binding of ME0052 to
oxidized ypTpx was determined to be 51 and 71 M to reduced
ypTpx (Fig. 5). TheKd for the C61Smutant revealed an approx-
imate 2-fold reduction in binding (93 M) (Fig. 5). The correla-
tion coefficients (r  0.8037, 0.9133, and 0.8440 for C61S,
reduced, and oxidized ypTpx) of the nonlinear best fits con-
firmed the strength of dependence between the amount of
FIGURE 2. Far Western probing to examine binding of ME0052-Bio to
putative target proteins. A, putative target proteins were cloned into
pET151 and expressed in E. coli BL21 (DE3) cells before lysis, separation, and
transfer to a nitrocellulose membrane. ME0052-Bio was used as a probe, and
interactions were detected using HRP-conjugated streptavidin. Proteins
probed were (or encoded by) Tpx (1), FolX (2), z2714 (3), z3974 (4), WrbA (5),
SurA (6), and StcE (7). Lane 8 contains bacterial lysate with no overexpressed
protein as a negative control. The same protocol was used to subsequently
probe proteins from E. coli O157 (EC), Y. pseudotuberculosis (YP), S. typhimu-
rium (ST), P. aeruginosa (PA), and S. flexneri (SF) or empty vector control (ve).
Panels show overexpression of target proteins: WrbA (B), Tpx (C), FolX and
FolB (D). Mutation of Tpx Cys-61 (C61S) affected binding of ME0052-Bio (E).
The additionof 200MunlabeledME0052 (F–H) strongly affected thebinding
of the biotinylated probe.
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bound drug and free drug. The stoichiometry was determined
to be one molecule of ME0052 compound bound per ypTpx
dimer.
WrbA, Tpx, and FolX Contribute to Bacterial Gene Regula-
tion—To assess any role of the three target proteins for the
expression and function of the T3SS, the corresponding gene
encoding each protein was deleted individually in both E. coli
O157 and Y. pseudotuberculosis. In addition, mutagenesis was
used tomodify ecTpx and introduce a serine residue in place of
the cysteine (Cys-61) that is essential for Tpx function. Thiswas
achieved by cloning the gene encoding ecTpx into a plasmid
(pDW141), site-directed mutagenesis, and then allelic
exchange to replace the wild-type copy of the tpx gene with the
mutant allele. The final strain, E. coli Tpx_C61S, was used in
subsequent assays to compare the phenotype of a deletion of
Tpxwith that of a non-functionalmutant. The growth rate of all
the E. coliO157mutants tested was not affected during culture
inMEM-HEPESmedium used for the transcriptomic profiling.
Using microarrays, the gene expression profile of each E. coli
O157 mutant was compared with that of the wild type. Tran-
scriptional changes for each mutant are listed in supplemental
Table S5.
The most striking finding was that some 27 genes were sig-
nificantly (p  0.05) affected in all four mutants. These genes
could be grouped into six Gene Ontology (GO) categories: cell
motility, locomotory behavior, localization of the cell, behavior,
FIGURE 3. NMR chemical shift perturbation of ypTpx by ME0052. A, 15N
HSQC spectra of 100 M ypTpx in the absence (black) and presence (red) of
200 M ME0052. A selection of the most perturbed cross peaks is indicated
with their assignments, and aperturbedglutamine side chain is indicated (Q).
B, a histogram of the weighted amide chemical shift perturbation by residue
reveals clusters of residues affected by ligand binding.
FIGURE4.Mappingof residues involved indrugbindingand liganddock-
ing. A, shown is a schematic representation of the structure of ecTpx (PDB
code 3HVV (43)) colored purpleby the shifts observedwhenME0052 is added
to ypTpx. Subunit A is in dark gray, and subunit B is in lighter gray. B, shown is
a surface representation of the ecTpx dimer, with the docked compound
ME0052 (cyan) based on the residues with the highest shift (purple sticks)
using Autodock Vina. The figures were created in PyMOL (56).
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locomotion, and flagellar motility. Nine genes required for fla-
gellar synthesis were significantly (2-fold change, p  0.05)
repressed in all four mutants. The genes encoding the T3SS
were also affected, but in contrast to the flagellar genes, these
were up-regulated, with the greatest changes seen for genes
encoding the basal apparatus of theT3SS, such as escJ, escC, and
escD (2-fold change, p  0.05). Previous work has demon-
strated that the expression of flagella and the T3SS of E. coli
O157 are cross-regulated to allow eithermotility or attachment
as appropriate (44). The strong repression of flagella and stim-
ulation of T3SS expression demonstrates that the three target
proteins we have identified are required for normal expression
and appropriate regulation of these key virulence factors.
The transcriptomic data are of particular interest when com-
pared with our previous work that determined the gene expres-
sion profile of E. coliO157 cultured in the presence or absence
of salicylidene acylhydrazide compounds (17). In this earlier
study we demonstrated that the addition of salicylidene acylhy-
drazides resulted in strong repression of the T3SS and up-reg-
ulation of flagella; that is, the reciprocal pattern of gene expres-
sion compared with the four mutants described here. Some 39
genes repressed by the addition of the inhibitors were up-reg-
ulated 1.5-fold in all mutants (15 of which were associated
with theT3SS), and conversely, 15 genes stimulated by addition
of the inhibitors were repressed in the mutants (13 of which
were associated with motility). This pattern of gene expression
can be most clearly seen by plotting on a single graph the -fold
change of the genes that were significantly (p 0.05) affected in
both studies (Fig. 6, A and B). The C61S mutant displayed a
transcriptional profile similar to that of the mutant with the
defined deletion. The transcriptomic data were validated by
quantitative PCR to examine transcript levels for selected
genes; transcript levels for fliC confirmed the differences
observed in flagellar expression with escJ tested to confirm the
up-regulation of the T3SS genes. For example, the E. coli
Tpx_C61S strain showed a 154-fold reduction of fliC expres-
FIGURE 5. AUC analysis of ME0052 binding to ypTpx. A line graph shows
the binding of ME0052 to purified ypTpx during AUC experiments. The lines
represent different redox states for Tpx: oxidized (black diamonds), reduced
(blue inverted triangles) and forced reduced mutant, C61S (green triangles).
The amount of boundME0052 was used to calculate the Kd values described
in the text.
FIGURE 6. Comparison of gene expression between bacteria cultured with salicylidene acylhydrazides and defined mutants. Microarray data were
filtered for transcripts that showed significant changes in gene expression (1.5-fold, p  0.05) when treated with salicylidene acylhydrazides (ME0052,
ME0053, ME0054) and that also showed5-fold changes in transcript abundance when compared with the definedmutants. A, shown is a graphic represen-
tation of gene expression. Red lines indicate genes associated with the T3SS, blue lines indicate transcripts associated with flagella andmotility, and gray lines
represent other genes.B, shown is aheatmapof geneexpression.Genenames are indicated to the rightof theheatmap, andexperimental conditions (inhibitor
or relevant genedeletion ormutation) are indicatedbelow. Coloringof boxes indicates relative expression (green, increased; red, repressed) as indicatedon the
left. Genes have been grouped according to their function or genetic location in three major classes:motility, pO157, and T3SS.
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sion and a 3-fold increase in escJ transcript level compared with
the wild type.
Tpx Regulates Flagellar and T3SS Expression in E. coli O157—
To determine whether the transcriptomic data translated into
actual phenotypes, analyses of flagellar expression and effects
on motility were tested using the E. coli O157 Tpx mutant.
Immunofluorescencemicroscopywas used to visualize flagellar
expression in the wild type, Tpx mutant, and in the comple-
mented mutant. A culture of the bacteria was performed in LB
medium at 28 °C as this is optimum for expression of flagella.
More than 90% of wild-type bacteria expressed flagella in these
conditions (Fig. 7A) with deletion of tpx reducing expression to
1% of bacteria (Fig. 7B). Restoration of flagellum expression
could be achieved by introduction of tpx on a low copy number
plasmid but not to wild-type levels (Fig. 7C). These data corre-
lated well with the bacterial motility, which was markedly
reduced for the Tpx mutant (supplemental Fig. S1). Treat-
ment of wild-type E. coli O157 with ME0055 results in an
increased proportion of bacteria expressing flagella (17). To
examine effects on the expression of the T3SS, bacteria were
cultured in DMEM. This medium provides an intermediate
level of expression in wild-type strains, allowing any increases
or decreases in the proportion of bacteria expressing the EspA
filaments, the needle-like structures used to deliver effector
proteins, to be measured. Some 45% of wild-type bacteria
express EspA filaments in DMEM (Fig. 7D and supplemental
Fig. S1), and deletion of tpx increased this proportion to 79%
(Fig. 7E and supplemental Fig. S1), a result that is consistent
with the transcriptomic data supporting the hypothesis that
Tpx is involved in the regulation of both flagella and the T3SS,
two key virulence factors in E. coli O157. Complementation
resulted in a phenotype similar to that of wild type (Fig. 7F and
supplemental Fig. S1).
Effect of Y. pseudotuberculosis Tpx andWrbA onVirulence in
Vitro—To examine the contribution of the target proteins to
pathogenesis, we created defined deletion strains of Tpx and
WrbA in Y. pseudotuberculosis and analyzed the effect on
T3SS and virulence. Analysis of Yop secretion revealed that the
secretion profiles of the Tpx and WrbA mutants were ele-
vated compared with that of wild-type bacteria (supplemental
Fig. S2). This result correlates well with the transcriptomic data
that also showed increased expression of genes associated with
the T3SS. Secretion from all three strains could be reduced by
the addition of 50 M ME0052 (supplemental Fig. S2), indicat-
ing that the overall phenotype associated with the salicylidene
acylhydrazide compounds results from affects on multiple tar-
get proteins. We also tested the ability of both Tpx and
WrbA mutants of Y. pseudotuberculosis to infect and kill a
J774Amacrophage-like cell line (10). Macrophage viability was
measured by the addition of calcein AM and subsequent fluo-
rescence analysis, with aYopB translocation-deficientmutant
as the negative control. Infection with wild-type bacteria
resulted in 46  16% viability compared with uninfected cells.
The Tpx and WrbAmutants were found to be as virulent as
the wild-type strain with 42 12 and 54 4% viability, respec-
tively. The addition of 25 M of ME00052 rescued the macro-
phages infected with wild-type bacteria or with the Tpx and
WrbA mutants, restoring viability such that no macrophages
were killed. Similarly, theYopBmutant was avirulent, with no
macrophages killed by this strain. These data demonstrate that
no single target protein appears to be responsible for the phe-
notype associated with the addition of the compounds.
DISCUSSION
The identity, function, and three-dimensional structure of
the target protein of a potential therapeutic compound consti-
tute key information in a drug development process based on
structure-based design (45, 46). The salicylidene acylhydrazide
class of T3SS inhibitorswas originally identified in a phenotypic
bacterial reporter-gene screen (8). This strategy provides com-
pounds that are active on the pathogenic organism and circum-
vents many of the drawbacks experienced in target-based
screening based on proteins obtained by genomics (23). The
salicylidene acylhydrazides have proved promising as T3SS
inhibitors (19), and to further explore the potential of this com-
pound class we have attempted to identify putative target pro-
teins using an affinity reagent approach (47). In this work we
have identified 16 proteins bound by the Affi-Gel-labeled com-
pound, ME0055-Aff. These putative protein targets of the sali-
cylidene acylhydrazides include WrbA, an NAD(P)H quinone
oxidoreductase, andTpx, a thiol peroxidase, both ofwhich have
been characterized in some detail (40, 41), and FolX, a dihydro-
neopterin-tri-P-epimerase. In contrast to WrbA and Tpx, the
cellular function of FolX has been poorly characterized. How
many of these proteins actually contribute to the phenotype
associated with the addition of salicylidene acylhydrazide com-
pounds is not clear. It has been established that metabolism is a
key factor in the regulation of expression of type III secretion in
P. aeruginosa (48). We would speculate that if the salicylidene
acylhydrazides affect multiple proteins, then there could be a
clear perturbation of normal metabolism, resulting in changes
in gene expression and protein function. However, some inter-
actions could have no consequence for virulence or result from
weak and nonspecific binding. It is also feasible that the unla-
FIGURE 7. Role of Tpx for appropriate expression of flagella and EspA
filaments. Bacteria were cultured in LB medium (A–C) or DMEM (D–F) to
promote expression of flagella or EspA filaments. Wild-type bacteria (A)
express flagellawhen visualized using immunofluorescencemicroscopy. The
Tpx mutant (B) is non-motile and aflagellate, a phenotype that could be par-
tially restored by introduction of plasmid-borne tpx (C). Culture in DMEM
results in 45%ofwild-type bacteria expressing EspA filaments (D). Deletion of
tpx increased this proportion to 79% of the population (E), and complemen-
tation by plasmid-borne tpx returned this to wild-type levels (F). Images are
composites created from differential interference contrast and immunofluo-
rescence overlays.
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beled compound binds additional, unidentified proteins, as the
modification of ME0055 by the addition of the spacer and Affi-
Gel bead could affect binding to target proteins by blocking
critical functional groups.Given thatwe successfully confirmed
binding for three of these target proteins using Far Western
blotting and showedNMRchemical shift perturbations for Tpx
using unlabeled ME0052, we would suggest that several of the
putative target proteins are likely to be true interacting partners
with the salicylidene acylhydrazides. Furthermore, we have
demonstrated that WrbA, Tpx, and FolX all contribute to the
normal regulation and expression of key virulence factors, spe-
cifically the T3SS and flagella, and would suggest that a combi-
nation of perturbations to normal protein activity for multiple
target proteins is most likely to explain the phenotype observed
upon the addition of the salicylidene acylhydrazides.
Quantitative structure-activity relationship (QSAR) models
have been computed for focused libraries (38, 39, 49, 50) using
a strategy based on statistical molecular design (51). TheQSAR
models for the salicylidene acylhydrazides were successfully
validated with an external test set, and several compounds
inhibited virulence in vitro (39). The QSARmodels were, how-
ever, hard to interpret, which is likely the result of the com-
pounds being evaluated in a cell-based assay and would be con-
sistent with the notion that they target multiple proteins. The
QSAR models reflect overall properties beneficial for interac-
tion with several proteins and other processes including cell
permeability. A mode of action that includes several targets is
beneficial from an antibiotic resistance perspective as the
pathogen must alter several proteins and pathways to escape
the drug. However, further optimization of the salicylidene
acylhydrazides against multiple targets is challenging (38, 39,
52), although polypharmacology is increasingly recognized as
important in drug discovery and development (53).
Given that the compounds affect the function of the T3SS of
several Gram-negative pathogens, the obvious implication is
that the different species share common protein targets that
result in similar phenotypes. At least threemechanisms of inhi-
bition have been suggested; they are direct effects on the T3SS
basal apparatus proteins (16), less-direct effects on proteins
that then affect T3SS expression and function (17), and possible
changes in iron availability (13). With reference to the latter
mechanism, our previous work indicated that for E. coli O157:
H7, no operons involved in iron metabolism were affected by
the addition of the salicylidene acylhydrazides and, therefore,
that iron availability was not sufficient to explain the inhibition
observedwith this strain (17). The three target proteinswe have
focused on are well conserved among Gram-negative patho-
gens; we have shown that both Tpx andWrbA from five differ-
ent pathogens are bound by the salicylidene acylhydrazides and
that the compounds bindFolX from three species. Additionally,
our identification of the strain that was insensitive to the effects
of the salicylidene acylhydrazides showed that this strain had
no genetic changes that would affect the proteins that comprise
the T3SS. This “insensitive” strain contained a mutant allele of
wrbA, encoding one of the proposed target proteins. Given the
large number of SNPs in this strain, we do not assume or con-
clude that this particular non-synonymous change results in
the “insensitivity,” but it is an interesting observation that this
target was identified by both approaches. Themajor conclusion
from this aspect of the study was that the T3SS was highly
conserved. Other genetic changes affecting cell wall structure,
ABC transporters, or efflux pumps could all account for the
phenotype observed with this strain. Overall, the weight of evi-
dence in the present study favors a mechanism based on indi-
rect effects that lead to changes in the regulation of the T3SS.
To understand the mechanism by which the salicylidene
acylhydrazides affect individual target proteins, we focused on
Tpx, a thiol peroxidase previously shown to be part of the oxi-
dative stress defense system (40). One important result was the
NMR chemical shift perturbation, as this showed that unla-
beled compound binds to the target protein involving spe-
cific residues that cluster to a discrete area near the active
site and the dimer interface. The binding site wasmodeled by
docking the compound onto ecTpx (PDB code 3HVV), high-
lighting the residues identified by the chemical shift NMR
experiments (Fig. 4).
Determination of both Kd and stoichiometry were achieved
using an AUC-based method. This gave a Kd of 	50 M and a
stoichiometry of 1 ME0052 molecule per ypTpx dimer. This
result correlates well with our Far Western data that showed
preferential binding of ME0052-Bio to the ypTpx dimer com-
pared with the monomer. The C61S mutant forms a less stable
dimer, resulting in the majority of the protein migrating as a
monomer after SDS-PAGE and less binding of theME0052-Bio
probe. In contrast, when the C61S protein was used for AUC
studies, the protein was present as a dimer and gave a Kd
approximately twice that of the wild type but with the same
stoichiometry as the wild-type protein. The lower Kd observed
for the C61S mutant is consistent with the NMR result that
identified Cys-61 as being a residue involved in binding of
ME0052.
Previous work has shown that Tpx protects against exoge-
nous hydrogen peroxide and is required for survival in macro-
phages (54). Our data also showed that a Y. pseudotuberculosis
Tpx mutant was as virulent against J774A macrophages as
wild-type bacteria and that the mutant remained sensitive to
ME0052. This result is in agreement with the E. coli transcrip-
tomic data and supports the hypothesis that the salicylidene
acylhydrazides act onmultiple targets. Although deletion of tpx
inE. coliO157 resulted in clear effects on gene transcription,we
were initially surprised to see an up-regulation of genes associ-
ated with the T3SS. Our working hypothesis was that the func-
tion of the T3SS proteins would be directly inhibited by the
addition of the compounds. However, the data from the arrays
showed that in E. coliO157, Tpx function leads to repression of
the T3SS. This can be attributed to the peroxidase activity of
Tpx rather than any direct regulatory effect of the protein itself,
as theC61Smutant displayed a transcriptional profile similar to
that of the mutant with the defined deletion. However, the
mechanisms bywhichTpx affects gene expression are not clear.
As both Tpx and WrbA function to protect against oxidative
stress, it does make biological sense for their activity to be
linked to activation of motility, allowing the bacteria to evade
such stresses. Previous work has shown a clear link between
bacterial response to numerous stresses and control of motility
(55).
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Given that the phenotype associated with addition of the
salicylidene acylhydrazide compounds is a repression of T3SS
expression, the implication is that these compounds may actu-
ally increase activity of Tpx andWrbA, thereby enhancing their
repressive effects on the T3SS. The addition of the salicylidene
acylhydrazide compounds does not directly affect expression of
tpx orwrbA (17), suggesting that the compoundsmight directly
activate or stabilize the enzymes. The preferential binding to
theTpx dimer coupledwith the stoichiometry andNMRchem-
ical shift assignment show that the compounds bind very close
to the active site of Tpx. It is possible that the binding of the
compound near the active site results in a positive effect on
protein activity. Future work will map the binding site of the
salicylidene acylhydrazide tomore target proteins, allowing any
common binding site to be identified, a key step on the route to
the development of this class of anti-virulence compounds.
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